107 related articles for article (PubMed ID: 9891222)
1. Flavone acetic acid enhances accumulation of IL-2 activated NK cells within established metastases.
Kitson RP; Ohashi M; Brunson KW; Goldfarb RH
In Vivo; 1998; 12(6):593-7. PubMed ID: 9891222
[TBL] [Abstract][Full Text] [Related]
2. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
[TBL] [Abstract][Full Text] [Related]
3. Enhanced anti-metastatic efficacy of IL-2 activated NK (A-NK) cells with novel benzothiazoles.
Goldfarb RH; Kitson RP; Brunson KW; Yoshino K; Hirota N; Kirii Y; Kotera Y; Inoue Y; Ohashi M
Anticancer Res; 1999; 19(3A):1663-7. PubMed ID: 10470098
[TBL] [Abstract][Full Text] [Related]
4. A novel drug delivery system using IL-2 activated NK cells and Zyn-linked doxorubicin.
Goldfarb RH; Koelemij R; Muirhead KA; Ohlsson-Wilhelm BM; Gray BD; Kuppen PJ; Basse PH; al-Atrash G; Kitson RP
In Vivo; 2000; 14(1):101-4. PubMed ID: 10757065
[TBL] [Abstract][Full Text] [Related]
5. Tumor blood supply and tumor localization by adoptively transferred IL-2 activated natural killer cells.
Nannmark U; Hokland ME; Agger R; Christiansen M; Kjaergaard J; Goldfarb RH; Bagge U; Unger M; Johansson BR; Albertsson PA; Basse PH
In Vivo; 2000; 14(5):651-8. PubMed ID: 11125549
[TBL] [Abstract][Full Text] [Related]
6. Microvessel origin and distribution in pulmonary metastases of B16 melanoma: implication for adoptive immunotherapy.
Nannmark U; Johansson BR; Bryant JL; Unger ML; Hokland ME; Goldfarb RH; Basse PH
Cancer Res; 1995 Oct; 55(20):4627-32. PubMed ID: 7553640
[TBL] [Abstract][Full Text] [Related]
7. IL-15 mediates anti-tumor effects after cyclophosphamide injection of tumor-bearing mice and enhances adoptive immunotherapy: the potential role of NK cell subpopulations.
Evans R; Fuller JA; Christianson G; Krupke DM; Troutt AB
Cell Immunol; 1997 Jul; 179(1):66-73. PubMed ID: 9259773
[TBL] [Abstract][Full Text] [Related]
8. Elimination of established liver metastases by human interleukin 2-activated natural killer cells after locoregional or systemic adoptive transfer.
Okada K; Nannmark U; Vujanovic NL; Watkins S; Basse P; Herberman RB; Whiteside TL
Cancer Res; 1996 Apr; 56(7):1599-608. PubMed ID: 8603408
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of intratumoral IL-12 and TNF-alpha microspheres: systemic anti-tumor immunity is mediated by both CD8+ CTL and NK cells.
Sabel MS; Arora A; Su G; Mathiowitz E; Reineke JJ; Chang AE
Surgery; 2007 Nov; 142(5):749-60. PubMed ID: 17981196
[TBL] [Abstract][Full Text] [Related]
10. Augmentation of IL-2 activated natural killer cell adoptive immunotherapy with cyclophosphamide.
Goldfarb RH; Ohashi M; Brunson KW; Kirii Y; Kotera Y; Basse PH; Kitson RP
Anticancer Res; 1998; 18(3A):1441-6. PubMed ID: 9673353
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of adoptive immunotherapy: improved methods for in vivo tracking of tumor-infiltrating lymphocytes and lymphokine-activated killer cells.
Wallace PK; Palmer LD; Perry-Lalley D; Bolton ES; Alexander RB; Horan PK; Yang JC; Muirhead KA
Cancer Res; 1993 May; 53(10 Suppl):2358-67. PubMed ID: 8485722
[TBL] [Abstract][Full Text] [Related]
12. Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery.
Da Costa ML; Redmond HP; Bouchier-Hayes DJ
J Surg Res; 2001 Dec; 101(2):111-9. PubMed ID: 11735264
[TBL] [Abstract][Full Text] [Related]
13. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of adoptively transferred A-NK cells in murine metastases: kinetics and role of interleukin-2.
Basse PH; Goldfarb RH; Herberman RB; Hokland ME
In Vivo; 1994; 8(1):17-24. PubMed ID: 8054506
[TBL] [Abstract][Full Text] [Related]
15. Morphological studies of effector cell-microvessel interactions in adoptive immunotherapy in tumor-bearing animals.
Nannmark U; Basse P; Johansson BR; Kuppen P; Kjergaard J; Hokland M
Nat Immun; 1996-1997; 15(2-3):78-86. PubMed ID: 9162266
[TBL] [Abstract][Full Text] [Related]
16. Cytolytic activities of IL-2 activated NK cells from MMTV/v-Ha-ras transgenic oncomice during tumor progression.
Goldfarb RH; Albertsson P; Nannmark U; Kitson RP
In Vivo; 1998; 12(6):589-92. PubMed ID: 9891221
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy of liver metastases of human gastric carcinoma with interleukin 2-activated natural killer cells.
Yasumura S; Lin WC; Hirabayashi H; Vujanovic NL; Herberman RB; Whiteside TL
Cancer Res; 1994 Jul; 54(14):3808-16. PubMed ID: 8033100
[TBL] [Abstract][Full Text] [Related]
18. Delivery of methoxymorpholinyl doxorubicin by interleukin 2-activated NK cells: effect in mice bearing hepatic metastases.
Quintieri L; Rosato A; Amboldi N; Vizler C; Ballinari D; Zanovello P; Collavo D
Br J Cancer; 1999 Mar; 79(7-8):1067-73. PubMed ID: 10098738
[TBL] [Abstract][Full Text] [Related]
19. Tracking of green fluorescent protein (GFP)-labeled LAK cells in mice carrying B16 melanoma metastases.
Takashima K; Fujiwara H; Inada S; Atsuji K; Araki Y; Kubota T; Yamagishi H
Anticancer Res; 2006; 26(5A):3327-32. PubMed ID: 17094448
[TBL] [Abstract][Full Text] [Related]
20. The infiltration of experimentally induced lung metastases of colon carcinoma CC531 by adoptively transferred interleukin-2-activated natural killer cells in Wag rats.
Kuppen PJ; Basse PH; Goldfarb RH; Van De Velde CJ; Fleuren GJ; Eggermont AM
Int J Cancer; 1994 Feb; 56(4):574-9. PubMed ID: 8112894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]